Literature DB >> 32964373

The association of diabetes and hyperglycemia with sepsis outcomes: a population-based cohort analysis.

Yarden Zohar1, Shani Zilberman Itskovich2, Shlomit Koren3,4, Ronit Zaidenstein1,4, Dror Marchaim5,4, Ronit Koren6,7.   

Abstract

The independent association of diabetes and hyperglycemia on the outcomes of sepsis remains unclear. We conducted retrospective cohort analyses of outcomes among patients with community-onset sepsis admitted to Shamir Medical Center, Israel (08-12/2016). Statistical associations were queried by Cox and logistic regressions, controlled for by matched propensity score analyses. Among 1527 patients with community-onset sepsis, 469 (30.7%) were diabetic. Diabetic patients were significantly older, with advanced complexity of comorbidities, and were more often exposed to healthcare environments. Despite statistically significant univariable associations with in-hospital and 90-day mortality, the adjusted Hazard Ratios (aHR) were 1.21 95% CI 0.8-1.71, p = 0.29 and 1.13 95% CI 0.86-1.49, p = 0.37, respectively. However, hyperglycemia at admission (i.e., above 200 mg/dl (was independently associated with: increased in-hospital mortality, aHR 1.48 95% CI 1.02-2.16, p = 0.037, 30-day mortality, aHR 1.8 95% CI 1.12-2.58, p = 0.001), and 90-day mortality, aHR 1.68 95% CI 1.24-2.27, p = 0.001. This association was more robust among diabetic patients than those without diabetes. In this study, diabetes was not associated with worse clinical outcomes in community-onset sepsis. However, high glucose levels at sepsis onset are independently associated with a worse prognosis, particularly among diabetic patients. Future trials should explore whether glycemic control could impact the outcomes and should be part of the management of sepsis, among the general adult septic population.

Entities:  

Keywords:  Community-acquired infections; Diabetes; Hyperglycemia; MDR; Multi-drug resistant; Sepsis

Mesh:

Year:  2020        PMID: 32964373     DOI: 10.1007/s11739-020-02507-9

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  48 in total

1.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

2.  Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study.

Authors:  Corinne Alberti; Christian Brun-Buisson; Hilmar Burchardi; Claudio Martin; Sergey Goodman; Antonio Artigas; Alberto Sicignano; Mark Palazzo; Rui Moreno; Ronan Boulmé; Eric Lepage; Roger Le Gall
Journal:  Intensive Care Med       Date:  2001-12-04       Impact factor: 17.440

3.  IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.

Authors:  K Ogurtsova; J D da Rocha Fernandes; Y Huang; U Linnenkamp; L Guariguata; N H Cho; D Cavan; J E Shaw; L E Makaroff
Journal:  Diabetes Res Clin Pract       Date:  2017-03-31       Impact factor: 5.602

Review 4.  Diabetes and infection: assessing the association with glycaemic control in population-based studies.

Authors:  Jonathan Pearson-Stuttard; Samkeliso Blundell; Tess Harris; Derek G Cook; Julia Critchley
Journal:  Lancet Diabetes Endocrinol       Date:  2015-12-03       Impact factor: 32.069

5.  Quantifying the risk of infectious diseases for people with diabetes.

Authors:  Baiju R Shah; Janet E Hux
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

6.  Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia.

Authors:  Michiel E Stegenga; Saskia N van der Crabben; Regje M E Blümer; Marcel Levi; Joost C M Meijers; Mireille J Serlie; Michael W T Tanck; Hans P Sauerwein; Tom van der Poll
Journal:  Blood       Date:  2008-03-03       Impact factor: 22.113

7.  Diabetes mellitus, fasting glucose, and risk of cause-specific death.

Authors:  Alexander Thompson; Emanuele Di Angelantonio; Pei Gao; Nadeem Sarwar; Sreenivasa Rao Kondapally Seshasai; Stephen Kaptoge; Peter H Whincup; Kenneth J Mukamal; Richard F Gillum; Ingar Holme; Inger Njølstad; Astrid Fletcher; Peter Nilsson; Sarah Lewington; Rory Collins; Vilmundur Gudnason; Simon G Thompson; Naveed Sattar; Elizabeth Selvin; Frank B Hu; John Danesh
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

Review 8.  Diabetes and sepsis: preclinical findings and clinical relevance.

Authors:  Philipp Schuetz; Pedro Castro; Nathan I Shapiro
Journal:  Diabetes Care       Date:  2011-03       Impact factor: 19.112

Review 9.  Epidemiology of severe sepsis.

Authors:  Florian B Mayr; Sachin Yende; Derek C Angus
Journal:  Virulence       Date:  2013-12-11       Impact factor: 5.882

10.  Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study.

Authors:  Jette B Kornum; Reimar W Thomsen; Anders Riis; Hans-Henrik Lervang; Henrik C Schønheyder; Henrik T Sørensen
Journal:  Diabetes Care       Date:  2008-05-16       Impact factor: 19.112

View more
  4 in total

1.  Association of Blood Glucose Level and Glycemic Variability With Mortality in Sepsis Patients During ICU Hospitalization.

Authors:  Zongqing Lu; Gan Tao; Xiaoyu Sun; Yijun Zhang; Mengke Jiang; Yu Liu; Meng Ling; Jin Zhang; Wenyan Xiao; Tianfeng Hua; Huaqing Zhu; Min Yang
Journal:  Front Public Health       Date:  2022-04-29

Review 2.  Anti-Hyperglycemic Agents in the Adjuvant Treatment of Sepsis: Improving Intestinal Barrier Function.

Authors:  Yi-Feng Wang; Jia-Wei Li; Da-Peng Wang; Ke Jin; Jiao-Jie Hui; Hong-Yang Xu
Journal:  Drug Des Devel Ther       Date:  2022-06-04       Impact factor: 4.319

Review 3.  Impact of diabetes mellitus on outcomes of patients with sepsis: an updated systematic review and meta-analysis.

Authors:  Li Jiang; Mengdi Cheng
Journal:  Diabetol Metab Syndr       Date:  2022-03-05       Impact factor: 3.320

4.  Glycosylated Hemoglobin as a Predictor of Sepsis and All-Cause Mortality in Trauma Patients.

Authors:  Feng Guo; Haitao Shen
Journal:  Infect Drug Resist       Date:  2021-07-01       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.